These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15138759)

  • 21. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.
    Lee AM; Jepson C; Hoffmann E; Epstein L; Hawk LW; Lerman C; Tyndale RF
    Biol Psychiatry; 2007 Sep; 62(6):635-41. PubMed ID: 17223085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.
    Berrettini WH; Wileyto EP; Epstein L; Restine S; Hawk L; Shields P; Niaura R; Lerman C
    Biol Psychiatry; 2007 Jan; 61(1):111-8. PubMed ID: 16876132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetic investigation of smoking cessation treatment.
    Lerman C; Shields PG; Wileyto EP; Audrain J; Pinto A; Hawk L; Krishnan S; Niaura R; Epstein L
    Pharmacogenetics; 2002 Nov; 12(8):627-34. PubMed ID: 12439223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion.
    Harris KJ; Okuyemi KS; Catley D; Mayo MS; Ge B; Ahluwalia JS
    Prev Med; 2004 Apr; 38(4):498-502. PubMed ID: 15020185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain.
    Toll BA; Leary V; Wu R; Salovey P; Meandzija B; O'Malley SS
    Addict Behav; 2008 Jan; 33(1):173-9. PubMed ID: 17587504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.
    Saxon AJ; Baer JS; Davis TM; Sloan KL; Malte CA; Fitzgibbons K; Kivlahan DR
    Nicotine Tob Res; 2003 Aug; 5(4):589-96. PubMed ID: 12959797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of five smoking cessation pharmacotherapies on smoking cessation milestones.
    Japuntich SJ; Piper ME; Leventhal AM; Bolt DM; Baker TB
    J Consult Clin Psychol; 2011 Feb; 79(1):34-42. PubMed ID: 21261432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion.
    Catley D; Harris KJ; Okuyemi KS; Mayo MS; Pankey E; Ahluwalia JS
    Nicotine Tob Res; 2005 Dec; 7(6):859-70. PubMed ID: 16298721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
    Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC
    Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
    Rose JE; Behm FM
    Nicotine Tob Res; 2017 Aug; 19(8):999-1002. PubMed ID: 29054128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.
    Fossati R; Apolone G; Negri E; Compagnoni A; La Vecchia C; Mangano S; Clivio L; Garattini S;
    Arch Intern Med; 2007 Sep; 167(16):1791-7. PubMed ID: 17846399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
    Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
    Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
    Gonzales D; Jorenby DE; Brandon TH; Arteaga C; Lee TC
    Addiction; 2010 Nov; 105(11):2002-13. PubMed ID: 20819082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
    West R; Baker CL; Cappelleri JC; Bushmakin AG
    Psychopharmacology (Berl); 2008 Apr; 197(3):371-7. PubMed ID: 18084743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of bupropion in the indigenous Maori population in New Zealand.
    Holt S; Timu-Parata C; Ryder-Lewis S; Weatherall M; Beasley R
    Thorax; 2005 Feb; 60(2):120-3. PubMed ID: 15681499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of sustained-release bupropion in specific patient populations for smoking cessation.
    Tonstad S
    Drugs; 2002; 62 Suppl 2():37-43. PubMed ID: 12109934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.